The hidden cost of genetic resistance to HIV-1

被引:0
|
作者
Jeremy Luban
机构
[1] University of Massachusetts Medical School,Program in Molecular Medicine
[2] University of Massachusetts Medical School,Department of Biochemistry and Molecular Pharmacology
来源
Nature Medicine | 2019年 / 25卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Assessment of more than 400,000 people over the age of 40 demonstrates that homozygosity for a CCR5 variant that prevents HIV-1 infection comes at the cost of increased rates of mortality.
引用
收藏
页码:878 / 879
页数:1
相关论文
共 50 条
  • [1] Retraction Note: The hidden cost of genetic resistance to HIV-1
    Jeremy Luban
    Nature Medicine, 2019, 25 (11) : 1796 - 1796
  • [2] RETRACTED: The hidden cost of genetic resistance to HIV-1 (Retracted Article)
    Luban, Jeremy
    NATURE MEDICINE, 2019, 25 (06) : 878 - 879
  • [3] HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria
    Oluniyi, Paul E.
    Ajogbasile, Fehintola, V
    Zhou, Shuntai
    Fred-Akintunwa, Iyanuoluwa
    Polyak, Christina S.
    Ake, Julie A.
    Tovanabutra, Sodsai
    Iroezindu, Michael
    Rolland, Morgane
    Happi, Christian T.
    AIDS, 2022, 36 (01) : 137 - 146
  • [4] HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde
    Goncalves, Paloma
    Barreto, Jorge
    Santos, Menilita
    Leal, Silvania
    Marcelino, Jose
    Abecasis, Ana
    Palladino, Claudia
    Taveira, Nuno
    AIDS, 2024, 38 (08) : 1101 - 1110
  • [5] Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance
    Fun, Axel
    Leitner, Thomas
    Vandekerckhove, Linos
    Daeumer, Martin
    Thielen, Alexander
    Buchholz, Bernd
    Hoepelman, Andy I. M.
    Gisolf, Elizabeth H.
    Schipper, Pauline J.
    Wensing, Annemarie M. J.
    Nijhuis, Monique
    RETROVIROLOGY, 2018, 15 : 1
  • [6] Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance
    Axel Fun
    Thomas Leitner
    Linos Vandekerckhove
    Martin Däumer
    Alexander Thielen
    Bernd Buchholz
    Andy I. M. Hoepelman
    Elizabeth H. Gisolf
    Pauline J. Schipper
    Annemarie M. J. Wensing
    Monique Nijhuis
    Retrovirology, 15
  • [7] HIV-1 genetic variation and drug resistance development
    Megens, Sarah
    Van Laethem, Kristel
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (11) : 1159 - 1178
  • [8] Latency: the hidden HIV-1 challenge
    Marcello, Alessandro
    RETROVIROLOGY, 2006, 3 (1)
  • [9] Latency: the hidden HIV-1 challenge
    Alessandro Marcello
    Retrovirology, 3